APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Component DTP Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Component DTP Vaccine Market Outlook and Growth Opportunities 2026

Report ID 173980220429 December 2025190 pages

Choose your research edition.

Industry ResearchComponent DTP Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Component DTP Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Component DTP Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Component DTP Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Component DTP Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Component DTP Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Component DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Component DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Component DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Component DTP Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Component DTP Vaccine market include GSK, Sanofi, Hualan Biological Vaccine, BioKangtai, CanSino Biologics, Walvax Biotechnology and CNBG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Component DTP Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Component DTP Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Component DTP Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Component DTP Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Component DTP Vaccine Segment by Company

GSK

Sanofi

Hualan Biological Vaccine

BioKangtai

CanSino Biologics

Walvax Biotechnology

CNBG

Component DTP Vaccine Segment by Type

Five Components

Three Components

Two Components

Component DTP Vaccine Segment by Application

Adults

Children

Component DTP Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Component DTP Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Component DTP Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Component DTP Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Component DTP Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Component DTP Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Component DTP Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Component DTP Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Component DTP Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Component DTP Vaccine industry.

Chapter 3: Detailed analysis of Component DTP Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Component DTP Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Component DTP Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Component DTP Vaccine Industry Trends Table 2. Component DTP Vaccine Industry Drivers Table 3. Component DTP Vaccine Industry Opportunities and Challenges Table 4. Component DTP Vaccine Industry Restraints Table 5. Global Component DTP Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Component DTP Vaccine Revenue Share by Company (2021-2026) Table 7. Global Component DTP Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Component DTP Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Component DTP Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Component DTP Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Component DTP Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Component DTP Vaccine Company, Product Type & Application Table 13. Global Component DTP Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Component DTP Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Five Components Table 18. Significant Companies of Three Components Table 19. Significant Companies of Two Components Table 20. Global Component DTP Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Component DTP Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Component DTP Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Component DTP Vaccine Sales Volume Share by Type (2021-2026) Table 24. Global Component DTP Vaccine Sales Volume Share by Type (2027-2032) Table 25. Global Component DTP Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Component DTP Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Component DTP Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Component DTP Vaccine Sales Value Share by Type (2021-2026) Table 29. Global Component DTP Vaccine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Adults Table 31. Significant Companies of Children Table 32. Global Component DTP Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Component DTP Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Component DTP Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Component DTP Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Component DTP Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Component DTP Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Component DTP Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Component DTP Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Component DTP Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Component DTP Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Component DTP Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Component DTP Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Component DTP Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Component DTP Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Component DTP Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Component DTP Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Component DTP Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Component DTP Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Component DTP Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Component DTP Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Component DTP Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Component DTP Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Component DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Component DTP Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Component DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Global Component DTP Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Component DTP Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Component DTP Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Component DTP Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Component DTP Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Component DTP Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Component DTP Vaccine Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Component DTP Vaccine Product Portfolio Table 68. GSK Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sanofi Component DTP Vaccine Product Portfolio Table 73. Sanofi Recent Development Table 74. Hualan Biological Vaccine Company Information Table 75. Hualan Biological Vaccine Business Overview Table 76. Hualan Biological Vaccine Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hualan Biological Vaccine Component DTP Vaccine Product Portfolio Table 78. Hualan Biological Vaccine Recent Development Table 79. BioKangtai Company Information Table 80. BioKangtai Business Overview Table 81. BioKangtai Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. BioKangtai Component DTP Vaccine Product Portfolio Table 83. BioKangtai Recent Development Table 84. CanSino Biologics Company Information Table 85. CanSino Biologics Business Overview Table 86. CanSino Biologics Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. CanSino Biologics Component DTP Vaccine Product Portfolio Table 88. CanSino Biologics Recent Development Table 89. Walvax Biotechnology Company Information Table 90. Walvax Biotechnology Business Overview Table 91. Walvax Biotechnology Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Walvax Biotechnology Component DTP Vaccine Product Portfolio Table 93. Walvax Biotechnology Recent Development Table 94. CNBG Company Information Table 95. CNBG Business Overview Table 96. CNBG Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. CNBG Component DTP Vaccine Product Portfolio Table 98. CNBG Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Component DTP Vaccine Distributors List Table 102. Component DTP Vaccine Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Component DTP Vaccine Product Image Figure 2. Global Component DTP Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Component DTP Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Component DTP Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Component DTP Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Component DTP Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Five Components Image Figure 10. Three Components Image Figure 11. Two Components Image Figure 12. Global Component DTP Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Component DTP Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Component DTP Vaccine Sales Volume Share by Type (2021-2032) Figure 15. Global Component DTP Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Component DTP Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Component DTP Vaccine Sales Value Share by Type (2021-2032) Figure 18. Adults Image Figure 19. Children Image Figure 20. Global Component DTP Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Component DTP Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Component DTP Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Component DTP Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Component DTP Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Component DTP Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Component DTP Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Component DTP Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Component DTP Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Component DTP Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Component DTP Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Component DTP Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Component DTP Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Component DTP Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Component DTP Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Component DTP Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Component DTP Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Component DTP Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Component DTP Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Component DTP Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Component DTP Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Component DTP Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Component DTP Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Five Components
  • Three Components
  • Two Components
Applications
  • Adults
  • Children
Companies covered
  • GSK
  • Sanofi
  • Hualan Biological Vaccine
  • BioKangtai
  • CanSino Biologics
  • Walvax Biotechnology
  • CNBG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Component DTP Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Component DTP Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Component DTP Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Component DTP Vaccine Market Dynamics
  1. 2.1 Component DTP Vaccine Industry Trends
  2. 2.2 Component DTP Vaccine Industry Drivers
  3. 2.3 Component DTP Vaccine Industry Opportunities and Challenges
  4. 2.4 Component DTP Vaccine Industry Restraints
3 Component DTP Vaccine Market by Company
  1. 3.1 Global Component DTP Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Component DTP Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Component DTP Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Component DTP Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Component DTP Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Component DTP Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Component DTP Vaccine Company Product Type and Application
  8. 3.8 Global Component DTP Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Component DTP Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Component DTP Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Component DTP Vaccine Market by Type
  1. 4.1 Component DTP Vaccine Type Introduction
  2. 4.1.1 Five Components
  3. 4.1.2 Three Components
  4. 4.1.3 Two Components
  5. 4.2 Global Component DTP Vaccine Sales Volume by Type
  6. 4.2.1 Global Component DTP Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Component DTP Vaccine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Component DTP Vaccine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Component DTP Vaccine Sales Value by Type
  10. 4.3.1 Global Component DTP Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Component DTP Vaccine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Component DTP Vaccine Sales Value Share by Type (2021-2032)
5 Component DTP Vaccine Market by Application
  1. 5.1 Component DTP Vaccine Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Component DTP Vaccine Sales Volume by Application
  5. 5.2.1 Global Component DTP Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Component DTP Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Component DTP Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Component DTP Vaccine Sales Value by Application
  9. 5.3.1 Global Component DTP Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Component DTP Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Component DTP Vaccine Sales Value Share by Application (2021-2032)
6 Component DTP Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Component DTP Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Component DTP Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Component DTP Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Component DTP Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Component DTP Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Component DTP Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Component DTP Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Component DTP Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Component DTP Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Component DTP Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Component DTP Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Component DTP Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Component DTP Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Component DTP Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Component DTP Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Component DTP Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Component DTP Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Component DTP Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Component DTP Vaccine Sales Value Share by Country, 2025 VS 2032
7 Component DTP Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Component DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Component DTP Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Component DTP Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Component DTP Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Component DTP Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Component DTP Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Component DTP Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Component DTP Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Component DTP Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Component DTP Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Component DTP Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Component DTP Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Component DTP Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Component DTP Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Component DTP Vaccine Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Hualan Biological Vaccine
  14. 8.3.1 Hualan Biological Vaccine Company Information
  15. 8.3.2 Hualan Biological Vaccine Business Overview
  16. 8.3.3 Hualan Biological Vaccine Component DTP Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hualan Biological Vaccine Component DTP Vaccine Product Portfolio
  18. 8.3.5 Hualan Biological Vaccine Recent Developments
  19. 8.4 BioKangtai
  20. 8.4.1 BioKangtai Company Information
  21. 8.4.2 BioKangtai Business Overview
  22. 8.4.3 BioKangtai Component DTP Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BioKangtai Component DTP Vaccine Product Portfolio
  24. 8.4.5 BioKangtai Recent Developments
  25. 8.5 CanSino Biologics
  26. 8.5.1 CanSino Biologics Company Information
  27. 8.5.2 CanSino Biologics Business Overview
  28. 8.5.3 CanSino Biologics Component DTP Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CanSino Biologics Component DTP Vaccine Product Portfolio
  30. 8.5.5 CanSino Biologics Recent Developments
  31. 8.6 Walvax Biotechnology
  32. 8.6.1 Walvax Biotechnology Company Information
  33. 8.6.2 Walvax Biotechnology Business Overview
  34. 8.6.3 Walvax Biotechnology Component DTP Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Walvax Biotechnology Component DTP Vaccine Product Portfolio
  36. 8.6.5 Walvax Biotechnology Recent Developments
  37. 8.7 CNBG
  38. 8.7.1 CNBG Company Information
  39. 8.7.2 CNBG Business Overview
  40. 8.7.3 CNBG Component DTP Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CNBG Component DTP Vaccine Product Portfolio
  42. 8.7.5 CNBG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Component DTP Vaccine Value Chain Analysis
  2. 9.1.1 Component DTP Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Component DTP Vaccine Sales Mode & Process
  6. 9.2 Component DTP Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Component DTP Vaccine Distributors
  9. 9.2.3 Component DTP Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst